Dyne Therapeutics (DYN) Other Non Operating Income (2019 - 2026)

Dyne Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 36.93% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $19.4 million (down 35.33% YoY), while the FY2025 annual figure was $22.0 million, down 16.99% from the prior year.
• Other Non Operating Income was $4.4 million for Q1 2026 at Dyne Therapeutics, up from $4.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $8.5 million in Q3 2024 to a low of $200000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $3.6 million across 5 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 657.47% in 2022, then tumbled 44.83% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $1.3 million in 2022, then slipped by 20.33% to $1.0 million in 2023, then surged by 620.57% to $7.6 million in 2024, then plunged by 44.83% to $4.2 million in 2025, then gained by 5.94% to $4.4 million in 2026.
• The last three Other Non Operating Income figures came in at $4.4 million (Q1 2026), $4.2 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.